MD NewsBiolimus Stents Noninferior to Sirolimus StentsDoctors LoungeBiodegradable biolimus-eluting stents are noninferior to durable polymer sirolimus-eluting stents in coronary artery disease, according to a study published online Nov. 9 in The Lancet…
Research and Markets: Heart Transplantation Global Clinical Trials Review, Q2 … – Business Wire (press release)
Research and Markets: Heart Transplantation Global Clinical Trials Review, Q2 …Business Wire (press release)Heart Transplantation Global Clinical Trials Review, Q2, 2011" provides data on the Heart Transplantation clinical trial scenario. This r…
NASDAQ Volume Active Stocks are – INCY, PSUN, ALXN, VSEA, BSFT – Retirement Planning
NASDAQ Volume Active Stocks are – INCY, PSUN, ALXN, VSEA, BSFTRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeuti…
Air views on organ donation scheme – South Wales Argus
Channel 4 NewsAir views on organ donation schemeSouth Wales ArgusVIEWS are being sought on proposals for a form of presumed consent for organ donation in Wales that experts believe will transform and save many lives. A Welsh Government White Paper prop…
BioMatrix Flex Stent Has Staying Power – MedPage Today
BioMatrix Flex Stent Has Staying PowerMedPage TodayExplain that a randomized trial in Europe showed at four years that a new biolimus-eluting biodegradable polymer stent was at least as good as the sirolimus-eluting durable polymer stent in the …
Kaup: Blood Donation awareness rally held – Bellevision
BellevisionKaup: Blood Donation awareness rally heldBellevisionBy Prakash Katpadi Kaup, 09 November 2011: Encouraging the blood donation voluntarily in Kaup Vidyaniketana Group of Education Society, a awareness rally was conducted. The rally which was …
EXCELLENT: Everolimus-eluting stent noninferior to sirolimus-eluting stent in … – Cardiology Today
EXCELLENT: Everolimus-eluting stent noninferior to sirolimus-eluting stent in …Cardiology TodayThe prospective, randomized, open-label, multicenter trial was designed to compare angiographic outcomes of everolimus-eluting stents vs. sirolimus-eluting…
Bristol-Myers Squibb (BMY) Crosses Pivot Point Support at $31.45 – Financial News Network Online
Bristol-Myers Squibb (BMY) Crosses Pivot Point Support at $31.45Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant reje…
Global Cardiac Biomarkers Market to Reach US$3.39 Billion by 2017, According … – San Francisco Chronicle (press release)
Global Cardiac Biomarkers Market to Reach US$3.39 Billion by 2017, According …San Francisco Chronicle (press release)A major factor driving growth in the global cardiovascular biomarker market is the ability of these biomarkers to make accurate predi…
AASLD: Many Liver Recipients Fare Well 20 Years Out – MedPage Today
AASLD: Many Liver Recipients Fare Well 20 Years OutMedPage TodaySAN FRANCISCO — Quality of life and mental health for 20-year survivors of liver transplantation was comparable to that of the general population, and pediatric recipients had similar phy…